Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.45 | 0.1 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.35 | 0.007 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.002 |
mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.23 | 0.1 |
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.0002 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-06 |
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.2 |
mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.04 |